Contact us via E-Mail
Follow us on LinkedInAll-time Popular Posts
A biobetter trastuzumab is on the way 
EGA president calls on Member States to boost market access for biosimilars in the EU 
3rd Forum on Biosimilars 
Pfizer starts biosimilar rituximab Phase I/II trial 
Indian Biosimilars Market 
World’s first biosimilar antibody* is approved in Korea 
A biosimilar manufacturer: Celltrion 
2 patents down, 1 to expire: Herceptin biosimilar coming to EU
Post Tagged with: "Monoclonal Antibodies"
August 1, 2017 8:26 AM
Celltrion and Teva announce U.S. FDA acceptance of BLA for proposed biosimilar to Herceptin (trastuzumab)
